To study this question, we enrolled 50 HIV-negative subjects with AFB smear-positive pulmonary TB and measured the Mtb specific CD4+ and CD8+ T cell responses at three time points during antituberculosis treatment. The gene discussed is CD8A; the disease is pulmonary tuberculosis.